SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Sep-23 4:29 PM View: | Valeant Pharmaceuticals Int... (BHC) | 05-Sep-23 | Payment of Exercise | 43,948 | $8.35 | $366,966.00 | (7%) 608.88K to 564.93K | |
06-Mar-23 4:48 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-23 | Grant | 142,678 | -- | -- | 30% 470.2K to 612.88K | |
06-Mar-23 4:48 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-23 | Payment of Exercise | 4,001 | $9.25 | $37,009.20 | (< 1%) 612.88K to 608.88K | |
04-Jan-23 4:36 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Jan-23 | Payment of Exercise | 6,310 | $6.28 | $39,626.80 | (1%) 476.51K to 470.2K | |
07-Sep-22 8:39 PM View: | Valeant Pharmaceuticals Int... (BHC) | 05-Sep-22 | Grant | 374,891 | -- | -- | 369% 101.62K to 476.51K | |
21-Aug-18 4:18 PM View: | Cambrex Corp. (CBM) | 20-Aug-18 | Option Exercise | 9,510 | $54.15 | $514,966.00 | 100% 0 to 9.51K | |
21-Aug-18 4:18 PM View: | Cambrex Corp. (CBM) | 20-Aug-18 | Market Option Sale | 9,510 | $63.42 | $603,098.00 | (100%) 9.51K to 0 | 41% |